Cargando…

CD38: T Cell Immuno-Metabolic Modulator

Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kar, Anwesha, Mehrotra, Shikhar, Chatterjee, Shilpak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408359/
https://www.ncbi.nlm.nih.gov/pubmed/32709019
http://dx.doi.org/10.3390/cells9071716
_version_ 1783567814383108096
author Kar, Anwesha
Mehrotra, Shikhar
Chatterjee, Shilpak
author_facet Kar, Anwesha
Mehrotra, Shikhar
Chatterjee, Shilpak
author_sort Kar, Anwesha
collection PubMed
description Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleotide (NAD(+)) levels have profound influence on diverse signaling and metabolic pathways of T cells, and hence dictate their functional fate. CD38, a major mammalian NAD(+) glycohydrolase (NADase), expresses on T cells following activation and appears to be an essential modulator of intracellular NAD(+) levels. The enzymatic activity of CD38 in the process of generating the second messenger cADPR utilizes intracellular NAD(+,) and thus limits its availability to different NAD(+) consuming enzymes (PARP, ART, and sirtuins) inside the cells. The present review discusses how the CD38-NAD(+) axis affects T cell activation and differentiation through interfering with their signaling and metabolic processes. We also describe the pivotal role of the CD38-NAD(+) axis in influencing the chromatin remodeling and rewiring T cell response. Overall, this review emphasizes the crucial contribution of the CD38(−)NAD(+) axis in altering T cell response in various pathophysiological conditions.
format Online
Article
Text
id pubmed-7408359
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74083592020-08-13 CD38: T Cell Immuno-Metabolic Modulator Kar, Anwesha Mehrotra, Shikhar Chatterjee, Shilpak Cells Review Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleotide (NAD(+)) levels have profound influence on diverse signaling and metabolic pathways of T cells, and hence dictate their functional fate. CD38, a major mammalian NAD(+) glycohydrolase (NADase), expresses on T cells following activation and appears to be an essential modulator of intracellular NAD(+) levels. The enzymatic activity of CD38 in the process of generating the second messenger cADPR utilizes intracellular NAD(+,) and thus limits its availability to different NAD(+) consuming enzymes (PARP, ART, and sirtuins) inside the cells. The present review discusses how the CD38-NAD(+) axis affects T cell activation and differentiation through interfering with their signaling and metabolic processes. We also describe the pivotal role of the CD38-NAD(+) axis in influencing the chromatin remodeling and rewiring T cell response. Overall, this review emphasizes the crucial contribution of the CD38(−)NAD(+) axis in altering T cell response in various pathophysiological conditions. MDPI 2020-07-17 /pmc/articles/PMC7408359/ /pubmed/32709019 http://dx.doi.org/10.3390/cells9071716 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kar, Anwesha
Mehrotra, Shikhar
Chatterjee, Shilpak
CD38: T Cell Immuno-Metabolic Modulator
title CD38: T Cell Immuno-Metabolic Modulator
title_full CD38: T Cell Immuno-Metabolic Modulator
title_fullStr CD38: T Cell Immuno-Metabolic Modulator
title_full_unstemmed CD38: T Cell Immuno-Metabolic Modulator
title_short CD38: T Cell Immuno-Metabolic Modulator
title_sort cd38: t cell immuno-metabolic modulator
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408359/
https://www.ncbi.nlm.nih.gov/pubmed/32709019
http://dx.doi.org/10.3390/cells9071716
work_keys_str_mv AT karanwesha cd38tcellimmunometabolicmodulator
AT mehrotrashikhar cd38tcellimmunometabolicmodulator
AT chatterjeeshilpak cd38tcellimmunometabolicmodulator